ColdPort Achieves Prestigious CEIV Pharma Certification, Elevating Pharmaceutical Cold Chain Standards

HOUSTON, TX — May 22, 2026 — ColdPort, the pioneering force in automated temperature-controlled logistics, proudly announced today that its flagship facilities have officially received the Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification from the International Air Transport Association (IATA). This globally recognized accreditation underscores ColdPort’s unwavering commitment to operational excellence and its capability to safely handle highly sensitive pharmaceutical and life-sciences products.

The CEIV Pharma certification is the industry’s most rigorous standard, designed to ensure that pharmaceutical products are handled, stored, and transported with strict adherence to the highest safety and compliance guidelines. Achieving this certification requires passing comprehensive audits of facilities, equipment, operations, and personnel training, confirming compliance with international regulations, including Good Distribution Practices (GDP).

"Securing the CEIV Pharma certification is a monumental milestone for ColdPort and a testament to the rigorous, technology-driven standards we have implemented across our network," stated David Simpkins, Founder and CEO of ColdPort. "In the pharmaceutical sector, the integrity of the cold chain is not just a matter of operational efficiency—it is a matter of patient safety. This certification assures our pharmaceutical partners that ColdPort operates at the absolute pinnacle of global compliance."

ColdPort’s facilities were uniquely positioned to achieve this certification due to their integration of state-of-the-art automation and advanced thermal mapping technologies. The company’s proprietary building management systems provide continuous, micro-level temperature and humidity monitoring, ensuring zero deviations from required storage parameters. Furthermore, ColdPort's automated storage and retrieval systems (AS/RS) minimize human intervention, significantly reducing the risk of temperature excursions during the handling process.

"The complexity of modern biologics and vaccines demands a logistics partner capable of absolute precision," Simpkins added. "Our facilities are engineered from the ground up to eliminate the vulnerabilities inherent in legacy cold storage. By combining automation with the strict protocols required by CEIV Pharma, we are providing pharmaceutical manufacturers with an unprecedented level of security and transparency."

The certification process involved extensive collaboration with independent validators who meticulously reviewed ColdPort’s quality management systems, risk assessment protocols, and emergency response procedures. The successful completion of this audit demonstrates ColdPort’s robust infrastructure and its dedicated team’s expertise in life-sciences logistics.

With the CEIV Pharma certification now in place, ColdPort is rapidly expanding its pharmaceutical client base, offering tailored solutions for the storage and distribution of critical medical supplies. The company is currently exploring further expansions to its dedicated healthcare logistics nodes, aimed at supporting the growing global demand for resilient pharmaceutical supply chains.

This achievement marks a significant step in ColdPort’s strategic roadmap to become the definitive leader in specialized cold storage, bridging the gap between advanced technology and critical healthcare infrastructure.

About ColdPort ColdPort is a premier developer and operator of next-generation, automated cold storage infrastructure. Leveraging advanced robotics, artificial intelligence, and sustainable design, ColdPort provides high-density, temperature-controlled logistics solutions for the food, beverage, and pharmaceutical industries.

Media Contact: ColdPort Public Relations media@gocoldport.com